Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NUVL Nuvalent Inc
- Stocks
- Healthcare
- NASDAQ: NUVL
Price (delayed)
$78.02
Market cap
$5.6B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.4
Enterprise value
$5.48B
Highlights
The equity has increased by 50% year-on-year but it has declined by 5% since the previous quarter
Nuvalent's net income has shrunk by 107% YoY and by 15% QoQ
The EPS has plunged by 83% YoY and by 12% from the previous quarter
Key stats
What are the main financial stats of NUVL
Market
Valuations
Earnings
Shares outstanding
71.81M
Market cap
$5.6B
Enterprise value
$5.48B
Price to earnings (P/E)
N/A
Price to book (P/B)
5.52
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$322.59M
Net income
-$300.86M
EBIT
-$300.32M
EBITDA
-$300.32M
Free cash flow
-$203.8M
Per share
Balance sheet
Liquidity
EPS
-$4.4
EPS diluted
-$4.4
Free cash flow per share
-$2.85
Book value per share
$14.12
Revenue per share
$0
TBVPS
$15.44
Total assets
$1.11B
Total liabilities
$94.75M
Debt
$0
Equity
$1.01B
Working capital
$1.01B
Debt to equity
0
Current ratio
14.48
Quick ratio
14.3
Net debt/EBITDA
0.4
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-29.3%
Return on equity
-31.3%
Return on invested capital
-37.8%
Return on capital employed
-29.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NUVL stock price
How has the Nuvalent stock price performed over time
Intraday
-0.09%
1 week
4.57%
1 month
14.42%
1 year
-4.4%
YTD
-0.33%
QTD
10.01%
Financial performance
How have Nuvalent's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$322.59M
Net income
-$300.86M
Gross margin
N/A
Net margin
N/A
Nuvalent's net income has shrunk by 107% YoY and by 15% QoQ
The operating income has dropped by 88% year-on-year and by 15% since the previous quarter
Price vs fundamentals
How does NUVL's price correlate with its fundamentals
Growth
What is Nuvalent's growth rate over time
Valuation
What is Nuvalent stock price valuation
P/E
N/A
P/B
5.52
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 83% YoY and by 12% from the previous quarter
The equity has increased by 50% year-on-year but it has declined by 5% since the previous quarter
NUVL's P/B is 8% lower than its last 4 quarters average of 6.0
Efficiency
How efficient is Nuvalent business performance
Nuvalent's return on equity has decreased by 18% YoY and by 5% QoQ
The ROA has decreased by 16% YoY and by 4.3% QoQ
The ROIC has declined by 4.1% year-on-year and by 3.6% since the previous quarter
Dividends
What is NUVL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NUVL.
Financial health
How did Nuvalent financials performed over time
The total liabilities has surged by 183% year-on-year and by 32% since the previous quarter
The total assets has soared by 56% year-on-year but it is down by 3.1% since the previous quarter
The debt is 100% smaller than the equity
The equity has increased by 50% year-on-year but it has declined by 5% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.